ZPCK

CAS No. 26049-94-5

ZPCK( Z-L-Phe chloromethyl ketone | NSC 251810 | SL 01 )

Catalog No. M13792 CAS No. 26049-94-5

ZPCK is a potent, pan autophagy inhibitor, inhibits the cargo degradation inside the vacuole and alters the process of autophagy in mammalian cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ZPCK
  • Note
    Research use only, not for human use.
  • Brief Description
    ZPCK is a potent, pan autophagy inhibitor, inhibits the cargo degradation inside the vacuole and alters the process of autophagy in mammalian cells.
  • Description
    ZPCK (NSC 251810;SL 01) is a potent, pan autophagy inhibitor, inhibits the cargo degradation inside the vacuole and alters the process of autophagy in mammalian cells; also modulates autophagic flux in a novel model plant, Aponogeton madagascariensis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Z-L-Phe chloromethyl ketone | NSC 251810 | SL 01
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    Autophagy
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    26049-94-5
  • Formula Weight
    331.796
  • Molecular Formula
    C18H18ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCC1=CC=CC=C1)N[C@H](C(CCl)=O)CC2=CC=CC=C2
  • Chemical Name
    N-[(1S)-3-chloro-2-oxo-1-(phenylmethyl)propyl]-carbamic acid, phenylmethyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mishra P, et al. Autophagy. 2017 Aug 9:1-17.
molnova catalog
related products
  • GSK4112

    A potent and selective small molecule Rev-erbα agonist with EC50 of 0.4 uM in biochemical assay.

  • GC7 Sulfate

    GC7 Sulfate is a potent inhibitor of deoxyhypusine synthase (DHS). Eukaryotic translation initiation factor 5A2 (eIF5A2) is the only known substrate for DHS, so GC7 inhibits the activation of eIF5A2 by inhibiting DHS activity.

  • Glycycoumarin

    Glycycoumarin is an estrogen agonist, it shows moderate inhibitory effects against CYP1A2 and CYP2B6.